Accrual Best Practices

for Biotech and Life Sciences

Billy Tamulynas (Sikich Finance Automation Expert) and Jotham Ty (CEO/Founder of Gappify) discuss why an automated approach to accrual management can eliminate errors, drive compliance, and increase the completeness and accuracy of expense reporting for Biotech and Life Sciences companies.

“Gappify has allowed us to scale our AP, FP&A and accounting functions in a way that didn’t require us to throw additional bodies at the problem.”

“By leveraging Gappify’s Accrual Cloud,we were able to automate these tedious, repetitive tasks and ultimately reduce our close timeline by 6 days.”

“In an era of new business models and changing accounting standards, accounting professionals need automation so that they can deliver fast, correct and smooth close processes. Gappify equips finance staff to keep pace with the speed of business, and enable finance transformation in an era of increasing complexity."

“Gappify is a cornerstone of our close management tech stack. They are pioneers in automated vendor accruals (which they execute perfectly!) and continue to add value through their innovative new features, including PO compliance monitoring and vendor spend insights."

About Gappify

Gappify, founded in 2016, is a cloud-based provider of accrual automation solutions for mid-market and enterprise accounting teams. The company is headquartered in New York City, with offices in Berkeley, California, Washington DC, and Manila, Philippines.

Its team consists of accountants and CPA’s from Big Four accounting firms and software innovators. Gappify is also supported by strategic advisors from some of the world’s most recognized technology companies and is affiliated with the top companies & accounting organizations.